Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020500 (
hyperoxaluria
)
912
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient who underwent jejunoileal bypass for
morbid obesity
developed servere renal failure associated with
hyperoxaluria
and renal oxalosis. Renal function improved and oxalate excretion decreased following hemodialysis and restoration of gastrointestinal continuity.
...
PMID:Acute reversible renal failure following jejunoileal bypass for morbid obesity: a clinical and pathological (EM) study of a case. 91 50
Five patients with jejunoileal shunt for
morbid obesity
in whom postshunt
hyperoxaluria
and recurrent urinary tract calculi developed are presented. All the stones were composed of calcium oxalate. The twenty-four hour urinary oxalic acid levels were also elevated in twenty of twenty-six patients who had had jejunoileal shunt for six months or longer. No correlation was present between urolithiasis and the degree of
hyperoxaluria
.
...
PMID:Hyperoxaluria and urinary tract calculi after jejunoileal bypass. 111 99
Enteric hyperoxaluria due to malabsorption syndromes has been well documented to cause renal calculi and chronic tubulointerstitial renal damage. Rarely, in the setting of intestinal bypass operations for
morbid obesity
, enteric
hyperoxaluria
has produced acute renal failure. We report two patients who suffered acute deterioration of renal function associated with increased intestinal absorption and renal excretion of oxalate associated with steatorrhea. One patient had a large portion of his small bowel resected many years prior to the onset of the renal failure and the second patient had chronic pancreatitis causing steatorrhea. Both patients had renal biopsy documentation of the acute nature of the tubular damage produced by oxalate deposition. The mechanisms of their deterioration of renal function may relate to sudden increases in steatorrhea in association with episodes of volume depletion. Enteric hyperoxaluria may be an easily overlooked and potentially preventable etiology of acute renal dysfunction.
...
PMID:Acute deterioration of renal function associated with enteric hyperoxaluria. 222 62
The intestinal permeation and 6-hour urinary recovery of small, multisized tracers, polyethyleneglycol 400 (PEG 400), was used to characterize gut permeability in nine patients after bypass surgery for
morbid obesity
and in ten healthy volunteers. In the patients, who also had
hyperoxaluria
, the urinary recovery of ingested PEG 400 was lower than in the healthy persons (10.9 and 24.7%). The patients also showed stronger intestinal exclusion of the larger polymers within the PEG 400.
...
PMID:Reduced intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with jejunoileal bypass. 651 79
The effect of oral calcium on oxalate absorption was studied in eight patients with secondary
hyperoxaluria
after jejunoileal bypass for
morbid obesity
during a standardized diet with a fixed supply of fat, calcium, and oxalate. A supplementary calcium dose of 2000 mg/day reduced renal oxalate excretion from 119 to 60 mg/24 h (median values, p < 0.01). Correspondingly, 14C-oxalate absorption decreased from 28% to 9% (p < 0.01). No statistically significant increase in urinary calcium was observed. The study shows that renal oxalate excretion in patients with enteric
hyperoxaluria
can be reduced by oral calcium. However, we doubt that it has any practical, clinical importance.
...
PMID:Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity. 743 95
Of 150 patients in whom jejunoileal bypass was performed for the treatment of
morbid obesity
, the intestinal bypass was converted to a gastric bypass in nine individuals. The indications for conversion have been weight regain, inadequate weight loss or pathologic
hyperoxaluria
with recurrent kidney stone formation. In all of our patients, dismantling of the jejunoileostomy and the gastric procedure was done simultaneously.
...
PMID:Conversion of malfunctioning intestinal bypass to gastric bypass. 744 33
Jejuno-ileal bypass has until recently been an accepted treatment for refractory
morbid obesity
. Although
hyperoxaluria
causing renal tract calculi is a well-recognized complication, we describe eight patients who developed significant renal failure attributable to
hyperoxaluria
resulting from this procedure, three requiring renal replacement therapy. We review the literature, describing 18 other cases with renal failure, the mechanisms of
hyperoxaluria
and its treatment. Because reversal of the bypass may result in stabilization or partial improvement of renal function, these patients require long-term follow-up of renal function.
...
PMID:Renal complications of jejuno-ileal bypass for obesity. 1118 82
Intestinal bypass was a popular surgical procedure for
morbid obesity
resulting, on average, in a 50 kg weight loss. We describe a 66-year-old woman who underwent the procedure 12 years earlier and subsequently presented with recurrent episodes of erythema nodosum-like lesions. Further investigations revealed
hyperoxaluria
, renal failure, deficiency of fat-soluble vitamins (causing night blindness, osteomalacia and easy bruising) and anaemia. Antibiotics led to only temporary remission and, as with 24-30% of similar cases, she underwent surgical reversal to prevent the complications from worsening.
...
PMID:Intestinal bypass syndrome presenting as erythema nodosum. 1511 6
Bariatric surgery is now recognized as a sure and effective way for weight reduction in
morbid obesity
. However some procedures induce intestinal malabsorption leading to enteric
hyperoxaluria
. So bariatric surgery could place these patients not only at risk for nephrolithiasis but also for oxalate induced nephropathy and chronic renal failure. Because of the growing incidence of obesity worldwide, physicians and patients should be aware of such potential complications. There is no mean to discuss this treatment because of its spectacular efficiency on obesity and its comorbidities. But it is necessary to choose the surgical technique according to the risk factors of the patients. Following surgery, preventive treatment strategies are indicated, such as modified dietary lifestyle and specific drugs as we suggested to limit or even avoid these complications. However observance could fail in the long term. In case of oxalate nephropathy, surgery may be proposed to restore the intestinal tract but with the risk of overweight relapse. To illustrate this matter, we report here significant observations of three patients, which, having successfully benefited from the same bariatric surgery, have presented lithiasic complications for two of them and oxalate nephropathy leading to chronic renal failure and hemodialysis for the third.
...
PMID:[Bariatric surgery, calcium oxalate urinary stones and oxalate nephropathy]. 2113 57
We report a case of 48-year-old woman with history of diabetes and hypertension, who presented with acute to chronic kidney injury. Sixteen months before presentation, she had undergone Roux-en-Y gastric by-pass (RYGB) for
morbid obesity
. Kidney biopsy showed lesions consistent with oxalate nephropathy and deposition of calcium oxalate crystals. An extensive workshop excluded other causes of kidney injury. The patient subsequently required dialysis with no improvement of renal function on follow-up. The mechanism by which patients develop
hyperoxaluria
after RYGB remains obscure; it is suggested that RYGB provokes fat malabsorption, which results in increased load of free fatty acid in the intestine. Thus, calcium binds to free fatty acids provoking reduced synthesis of calcium oxalate. Consequently, increased quantity of oxalate remains free and is absorbed in the intestine causing
hyperoxaluria
. Similar to our case, oxalate nephropathy after RYGB is seen in patients with diabetes, hypertension and chronic kidney injury. Treatment includes low-fat, low-oxalate diet along with administration of calcium supplements. Unfortunately, prognosis is rather poor with the majority of patients eventually requiring permanent dialysis. Therefore, patients with history of chronic kidney disease undergoing RYGB should be closely monitored, particularly those with long standing history of diabetes and hypertension.
...
PMID:Oxalate nephropathy in a diabetic patient after gastric by-pass. 2126 87
1
2
Next >>